UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

INDEPENDENT REVIW PANEL ASSESSMENTS: AN ALTERNATIVE ROUTE TO MARKET ACCESS IN SCOTLAND?

Value in health, 2016-05, Vol.19 (3), p.A263-A264

Macaulay, R

2016

Volltextzugriff (PDF)

DOES PRACTICE MAKE PERFECT? DOES THE NUMBER OF NICE AND SMC SUBMISSIONS A COMPANY MAKES CORRELATE WITH SUCCESS RATES?

Value in health, 2016-05, Vol.19 (3), p.A263-A263

Macaulay, R

2016

Volltextzugriff (PDF)

THE RISE OF INDICATION-SPECIFIC PRICING IN THE UNITED KINGDOM?

Value in health, 2016-05, Vol.19 (3), p.A262-A262

Macaulay, R

2016

Volltextzugriff (PDF)

ARE THE SMC GETTING NICER? A TIME-TREND ANALYSIS OF NICE AND SMC APPRAISAL OUTCOMES

Value in health, 2016-05, Vol.19 (3), p.A262-A262

Macaulay, R

2016

Volltextzugriff (PDF)

NOT NICE – NOW WHAT?

Value in health, 2016-05, Vol.19 (3), p.A263-A263

Macaulay, R

2016

Volltextzugriff (PDF)

FDA breakthrough Therapy status - a systematic analysis of all Therapies approved under this new expedited Approval Pathway

Value in health, 2015-05, Vol.18 (3), p.A75-A76

Macaulay, R

2015

Volltextzugriff (PDF)

The trouble with cost-utility HTA bodies: they should determine the Price not react to it

Value in health, 2015-05, Vol.18 (3), p.A90-A90

Macaulay, R

2015

Volltextzugriff (PDF)

Reimbursement Approval of Oncology Drugs In Canada Supported By a Data Package Lacking Phase III Trial Data

Value in health, 2015-05, Vol.18 (3), p.A214-A215

Macaulay, R

2015

Volltextzugriff (PDF)

Encouraging orphan designation for new ebola treatments – could this do more harm than good?

Value in health, 2015-05, Vol.18 (3), p.A243-A244

Macaulay, R

2015

Volltextzugriff (PDF)

Association between endometritis diagnosis using a novel intravaginal device and reproductive performance in dairy cattle

Animal reproduction science, 2007-05, Vol.99 (1), p.9-23

2007

Volltextzugriff (PDF)

What The English Could Learn From The Irish: Making The Nice Approval Process More Cost-Effective

Value in health, 2014-11, Vol.17 (7), p.A440-A440

Macaulay, R

2014

Volltextzugriff (PDF)

Comparing How Single Arm Phase II Trial Data Can Support Approval of Oncologics by European Health Technology Assessment Bodies

Value in health, 2014-11, Vol.17 (7), p.A659-A659

Macaulay, R

2014

Volltextzugriff (PDF)

The Cancer Drugs Fund: A Systematic Analysis of the Requirements For Inclusion on the English National List of Drugs for Priority Funding

Value in health, 2014-11, Vol.17 (7), p.A659-A659

Macaulay, R

2014

Volltextzugriff (PDF)

Comparing Access to Drugs Through the CDF and by Nice – The CDF Stipulate Stricter Clinical Criteria but will Also Approve Funding for Off-Label Usage

Value in health, 2014-11, Vol.17 (7), p.A659-A660

Macaulay, R

2014

Volltextzugriff (PDF)

Evidence for Regional Variation in the Appraisal of Individual Cancer Drugs Fund Requests

Value in health, 2014-11, Vol.17 (7), p.A657-A657

Macaulay, R

2014

Volltextzugriff (PDF)

Application of A ‘Nice Post-Hoc B/S Analysis' To the Nice Appraisal Process

Value in health, 2014-11, Vol.17 (7), p.A436-A436

Macaulay, R

2014

Volltextzugriff (PDF)

Media Coverage of the Nice First Draft Consultation Guidance for Trastuzumab Emantansine (Kadcyla) In Breast Cancer

Value in health, 2014-11, Vol.17 (7), p.A659-A659

Macaulay, R

2014

Volltextzugriff (PDF)

Comparing Psychometric Properties of the NIH Toolbox Cognition Battery to Gold-Standard Measures in Socioeconomically Diverse Older Adults

Archives of clinical neuropsychology, 2021-11, Vol.36 (8), p.1523–1534-1523–1534

2021

Volltextzugriff (PDF)

Initial development of skill with a reversed bicycle and a case series of experienced riders

Scientific reports, 2024-02, Vol.14 (1), p.4334-4334, Article 4334

2024

Volltextzugriff (PDF)

Evaluating Criticism Of The Fda Accelerated Approval Pathway - Ema Evaluation Of Drugs That Have Been Withdrawn Following Accelerated Approval By The Fda

Value in health, 2014-05, Vol.17 (3), p.A13-A13

Macaulay, R

2014

Volltextzugriff (PDF)

Evidence for a Lowered Threshold for FDA Approval of Oncologics Based on Single-Arm Phase II Data, Compared to the EMA

Value in health, 2014-05, Vol.17 (3), p.A98-A98

Macaulay, R

2014

Volltextzugriff (PDF)

Downfalls of the FDA Accelerated Approval Pathway – Stringent Controls Must be Invoked to Ensure Prompt Submission of Follow-Up Confirmatory Trial Data

Value in health, 2014-05, Vol.17 (3), p.A98-A98

Macaulay, R

2014

Volltextzugriff (PDF)

12 weeks of strength training improves fluid cognition in older adults: A nonrandomized pilot trial

PloS one, 2021-07, Vol.16 (7), p.e0255018-e0255018

2021

Volltextzugriff (PDF)

Effects of intermittent seating upright, lower body negative pressure, and exercise on functional tasks performance after head-down tilt bed rest

Frontiers in physiology, 2024-09, Vol.15, p.1442239

2024

Volltextzugriff (PDF)

EMA Approval of Drugs on the Basis of Pivotal Non-Comparative Phase II Trial Data

Value in health, 2013-11, Vol.16 (7), p.A324-A324

Macaulay, R

2013

Volltextzugriff (PDF)

1 – 25 von 1.520

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.358)
Mit Volltextzugriff
(1.262)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(652)
Life Sciences & Biomedicine
(500)
Humans
(348)
Female
(185)
Biological And Medical Sciences
(158)
Male
(157)
Animals
(118)
Medical Sciences
(111)
Physical Sciences
(111)
Social Sciences
(91)
Middle Aged
(88)
Aged
(87)
Neurosciences & Neurology
(67)
Adult
(64)
Technology
(64)
Internal Medicine
(62)
Oncology
(59)
Fundamental And Applied Biological Sciences. Psychology
(55)
Exact Sciences And Technology
(51)
Neurosciences
(49)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

INDEPENDENT REVIW PANEL ASSESSMENTS: AN ALTERNATIVE ROUTE TO MARKET ACCESS IN SCOTLAND?

DOES PRACTICE MAKE PERFECT? DOES THE NUMBER OF NICE AND SMC SUBMISSIONS A COMPANY MAKES CORRELATE WITH SUCCESS RATES?

THE RISE OF INDICATION-SPECIFIC PRICING IN THE UNITED KINGDOM?

ARE THE SMC GETTING NICER? A TIME-TREND ANALYSIS OF NICE AND SMC APPRAISAL OUTCOMES

NOT NICE – NOW WHAT?

FDA breakthrough Therapy status - a systematic analysis of all Therapies approved under this new expedited Approval Pathway

The trouble with cost-utility HTA bodies: they should determine the Price not react to it

Reimbursement Approval of Oncology Drugs In Canada Supported By a Data Package Lacking Phase III Trial Data

Encouraging orphan designation for new ebola treatments – could this do more harm than good?

Association between endometritis diagnosis using a novel intravaginal device and reproductive performance in dairy cattle

What The English Could Learn From The Irish: Making The Nice Approval Process More Cost-Effective

Comparing How Single Arm Phase II Trial Data Can Support Approval of Oncologics by European Health Technology Assessment Bodies

The Cancer Drugs Fund: A Systematic Analysis of the Requirements For Inclusion on the English National List of Drugs for Priority Funding

Comparing Access to Drugs Through the CDF and by Nice – The CDF Stipulate Stricter Clinical Criteria but will Also Approve Funding for Off-Label Usage

Evidence for Regional Variation in the Appraisal of Individual Cancer Drugs Fund Requests

Application of A ‘Nice Post-Hoc B/S Analysis' To the Nice Appraisal Process

Media Coverage of the Nice First Draft Consultation Guidance for Trastuzumab Emantansine (Kadcyla) In Breast Cancer

Comparing Psychometric Properties of the NIH Toolbox Cognition Battery to Gold-Standard Measures in Socioeconomically Diverse Older Adults

Initial development of skill with a reversed bicycle and a case series of experienced riders

Evaluating Criticism Of The Fda Accelerated Approval Pathway - Ema Evaluation Of Drugs That Have Been Withdrawn Following Accelerated Approval By The Fda

Evidence for a Lowered Threshold for FDA Approval of Oncologics Based on Single-Arm Phase II Data, Compared to the EMA

Downfalls of the FDA Accelerated Approval Pathway – Stringent Controls Must be Invoked to Ensure Prompt Submission of Follow-Up Confirmatory Trial Data

12 weeks of strength training improves fluid cognition in older adults: A nonrandomized pilot trial

Effects of intermittent seating upright, lower body negative pressure, and exercise on functional tasks performance after head-down tilt bed rest

EMA Approval of Drugs on the Basis of Pivotal Non-Comparative Phase II Trial Data

Suchergebnisse filtern